Company patents

Relign Corporation

Relign Corporation's patent strategy is almost entirely concentrated in Medical Diagnostics & Surgery, representing 100.0% of its portfolio. Surprisingly, despite this singular focus, patenting in this core area has seen a significant decline, with a -31.2% YoY drop in 2025 and a further -90.9% decline so far in 2026, suggesting a potential shift away from active innovation in its primary domain.

Patent Trend by Technology Area

Yearly patent publications since 2023

Product themes

Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.

46 US filings (since 2023) · 3 categories · 3 themes

Patents

Showing 1-10 of 82

Page 1 of 9